Efficacy of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer

被引：3

作者：

Koizumi, Tomonobu ^{[1
]}

Sasaki, Shigeru ^{[1
]}

Sakamoto, Akiyuki ^{[1
]}

Kobayashi, Takashi ^{[1
]}

机构：

[1] Shinshu Univ, Sch Med, Dept Comprehens Canc Therapy, Nagano 3908621, Japan

来源：

ANNALS OF PALLIATIVE MEDICINE | 2013年 / 2卷 / 03期

关键词：

EGFR-TKI; stereotactic radiosurgery; EGFR mutation;

D O I：

10.3978/j.issn.2224-5820.2013.07.01

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Treatment and control of brain metastases are important in patients with non-small cell lung cancer (NSCLC). Whole brain radiation therapy (WBRT) has a major role in the management of brain metastasis. Recently, efficacy erlotinib plus concurrent WBRT for patients with brain metastases from NSCLC was reported. Herein, we discussed the results and commented the clinical matters in future.

引用

页码：111 / 113

页数：3

共 50 条

[1] Erlotinib plus concurrent whole-brain radiation therapy for non-small cell lung cancers patients with multiple brain metastases
Ulahannan, Danny
Lee, Siow-Ming
TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (02) : 208 - 211
[2] Phase II Study of Erlotinib with Concurrent Whole-brain Radiation Therapy for Patients with Brain Metastases from Non-small Cell Lung Cancer
Welsh, J. W.
Kim, E.
Amini, A.
Allen, P.
Chang, J.
Komaki, R.
Nguyen, N.
Holt, J.
Erdman, D.
Stea, B.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S136 - S136
[3] PHASE II STUDY OF ERLOTINIB WITH CONCURRENT WHOLE-BRAIN RADIATION THERAPY FOR PATIENTS WITH BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
Welsh, James
Amini, Arya
Kim, Edward
Allen, Pamela K.
Chang, Joe Y.
Garland, Linda
Komaki, Ritsuko
Stea, Baldassarre
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1587 - S1587
[4] Phase II study of erlotinib with concurrent whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer.
Welsh, J.
Amini, A.
Kim, E. S.
Allen, P.
Chang, J. Y.
Garland, L. L.
Holt, J.
Erdman, D.
Komaki, R.
Stea, B.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[5] Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non-Small-Cell Lung Cancer
Welsh, James W.
Komaki, Ritsuko
Amini, Arya
Munsell, Mark F.
Unger, Wyatt
Allen, Pamela K.
Chang, Joe Y.
Wefel, Jeffrey S.
McGovern, Susan L.
Garland, Linda L.
Chen, Su S.
Holt, Jamie
Liao, Zhongxing
Brown, Paul
Sulman, Erik
Heymach, John V.
Kim, Edward S.
Stea, Baldassarre
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (07) : 895 - 902
[6] A phase I study of cediranib plus whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer
Eichler, A. F.
Shih, H. A.
Sequist, L. V.
Wen, P. Y.
Jain, R. K.
Sorensen, A. G.
Batchelor, T.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[7] Concurrent whole-brain radiation therapy combined with chemotherapy consisted of carboplatin and paclitaxel in non-small cell lung cancer patients with brain metastases
Kogure, Y
Takahashi, T
Ueda, S
Ebisawa, M
Asai, G
Harada, H
Yamamoto, N
LUNG CANCER, 2005, 49 : S253 - S253
[8] Efficacy and safety of recombinant human endostatin combined with whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer
Chen, Lingjuan
Tong, Fang
Peng, Ling
Huang, Yu
Yin, Ping
Feng, Yue
Cheng, Shishi
Wang, Jing
Dong, Xiaorong
RADIOTHERAPY AND ONCOLOGY, 2022, 174 : 44 - 51
[9] Whole brain radiotherapy with concurrent erlotinib for brain metastases from non-small cell lung cancer: A phase I study
Lind, J. S.
Lagerwaard, F. J.
Smit, E. F.
Senan, S.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[10] Should Erlotinib Be Coadministered With Whole-Brain Radiotherapy in Patients With Brain Metastases and Non-Small-Cell Lung Cancer?
Chamberlain, Marc C.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3164 - 3165

← 1 2 3 4 5 →